Evidence map›Paper›PMID 40596540›Full record

ArticleScientific reports2025

SARS-CoV-2 bioaerosol transmission in experimentally infected American mink.

Rasmus Malmgren, Vinaya Venkat, Jenni Virtanen, Kristel Kegler, Thanakorn Niamsap, Lauri Kareinen, Olga Kivelä, Nina Atanasova, Pamela Österlund, Teemu Smura and 7 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Rasmus MalmgrenMolecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Viikinkaari 9, Helsinki, 00790, Finland. rasmus.malmgren@helsinki.fi.
Vinaya VenkatDepartment of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, 00014, Finland.
Jenni VirtanenDepartment of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, 00014, Finland.
Kristel KeglerDepartment of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, 00014, Finland.
Thanakorn NiamsapDepartment of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, 00014, Finland.
Lauri KareinenDepartment of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, 00014, Finland.
Olga KiveläMolecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Viikinkaari 9, Helsinki, 00790, Finland.
Nina AtanasovaMolecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Viikinkaari 9, Helsinki, 00790, Finland.
Pamela ÖsterlundDepartment of Virology, University of Helsinki, Helsinki, 00014, Finland.
Teemu SmuraDepartment of Virology, University of Helsinki, Helsinki, 00014, Finland.
Antti SukuraDepartment of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, 00014, Finland.
Lara DutraDepartment of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, 00014, Finland.
Olli VapalahtiDepartment of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, 00014, Finland.
Heli NordgrenDepartment of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, 00014, Finland.
Ravi KantDepartment of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, 00014, Finland.
Tarja SironenDepartment of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, 00014, Finland.
Kirsi AaltonenDepartment of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, 00014, Finland.

Funding

Business Finland 4917/31/2021Research Council of Finland 336490VEO-European Union's Horizon 2020 874735
6 · The paper itself

Abstract

The SARS-CoV-2 BA.1 (Omicron) variant, which emerged in late 2021, is more transmissible than earlier variants but causes milder symptoms in humans. Mink farms, where animals are housed in close quarters, present a high risk for virus transmission and mutation, necessitating strict control measures due to documented cases of mink-to-human and human-to-mink transmission. Hence, we aimed to detect infectious airborne SARS-CoV-2 using BioSampler-air collectors and to investigate aerosol transmission between groups of American mink (Neovison vison). Two groups (male and female) were infected with the BA.1 variant, and samples were collected from aerosols, saliva, feces, and surfaces. The results indicated that infectious viruses were predominantly detected in aerosol samples over a three-day period in both groups. Surface, saliva, and fecal samples also showed potential for virus transmission. Notably, infectious viruses were cultivated from aerosol samples, confirming aerosol transmission among American mink. This study highlights the importance of immediate sample culturing to improve infectious virus detection and emphasizes the need for enhanced preventive measures on mink farms to mitigate the spread of viruses.

Indexed as

COVID-19MinkSARS-CoV-2AerosolsAir MicrobiologyAnimalsFecesFemaleHumansMaleSalivaAerosols

Identifiers

PMID40596540
PMCPMC12217755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.